Automate Your Wheel Strategy on ZTS
With Tiblio's Option Bot, you can configure your own wheel strategy including ZTS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ZTS
- Rev/Share 20.7462
- Book/Share 10.3999
- PB 15.1732
- Debt/Equity 1.4501
- CurrentRatio 1.7362
- ROIC 0.2254
- MktCap 70253822400.0
- FreeCF/Share 5.0961
- PFCF 30.7996
- PE 28.0505
- Debt/Assets 0.4788
- DivYield 0.0118
- ROE 0.5132
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | ZTS | Stifel | Buy | Hold | -- | $160 | June 18, 2025 |
News
Trade Tracker: Sarat Sethi buys Zoetis and sells Elanco
Published: April 23, 2025 by: CNBC Television
Sentiment: Neutral
Sarat Sethi, Managing Partner at DCLA, joins CNBC's "Halftime Report" to detail his latest trades.
Read More
This Magnificent Dividend Stock Has Increased Its Payouts by 500% in 10 Years
Published: April 03, 2025 by: The Motley Fool
Sentiment: Positive
There are many dividend stocks on equity markets, but not all are attractive to income investors. Those that go beyond paying a quarterly payout but also consistently raise their dividends -- all while having robust businesses that can support their dividend programs for a long time -- are the ones income-seekers want.
Read More
Zoetis Inc. (ZTS) CFO Wetteny Joseph Hosts Barclays 27th Annual Global Healthcare (Transcript)
Published: March 11, 2025 by: Seeking Alpha
Sentiment: Neutral
Zoetis Inc. (NYSE:ZTS ) Barclays 27th Annual Global Healthcare March 11, 2025 10:30 AM ET Company Participants Wetteny Joseph - Chief Financial Officer Conference Call Participants Balaji Prasad - Barclays Balaji Prasad Good morning, everyone. Thanks for joining us at the Barclays Healthcare Conference.
Read More
My Top 15 High-Growth Dividend Stocks For March 2025
Published: March 03, 2025 by: Seeking Alpha
Sentiment: Positive
The SPDR S&P 500 ETF Trust stumbled in February but managed to maintain a positive return in 2025. The Top 15 dividend growth stocks for March 2025 offer an average dividend yield of 1.13% and appear to be about 25% undervalued based on dividend yield theory. Since its inception in September 2020, the watch list has achieved a 10.63% compound annual growth rate.
Read More
Zoetis Inc. (ZTS) BofA Securities 2025 Animal Health Summit (Transcript)
Published: February 28, 2025 by: Seeking Alpha
Sentiment: Neutral
Zoetis Inc. (NYSE:ZTS ) BofA Securities 2025 Animal Health Summit February 27, 2025 1:20 PM ET Company Participants Wetteny Joseph - CFO Conference Call Participants Michael Ryskin - Bank of America Operator Ladies and gentlemen, the program is about to begin. At this time, it is my pleasure to turn the program over to your host, Michael Ryskin.
Read More
Zoetis CEO on bird flu vaccine
Published: February 18, 2025 by: Bloomberg Markets and Finance
Sentiment: Positive
Zoetis received a conditional license for its bird flu vaccine from the US Department of Agriculture to help fight the spread of the disease on poultry farms. Here's what CEO Kristin Peck had to say
Read More
Why Zoetis Stock Took Another Tumble Today
Published: February 14, 2025 by: The Motley Fool
Sentiment: Negative
One day after unveiling quarterly results that disappointed the market and engendered a stock sell-off, Zoetis (ZTS -4.49%) shares again tumbled. As of late-session trading on Friday, they were down by 4%, in no small part due to several analyst price target cuts.
Read More
US grants conditional clearance to Zoetis' bird flu vaccine for poultry
Published: February 14, 2025 by: Reuters
Sentiment: Positive
Zoetis said on Friday its bird flu vaccine has received the U.S. Department of Agriculture's conditional license for use in poultry.
Read More
Zoetis CEO says Avian Flu vaccine for poultry gets USDA approval
Published: February 13, 2025 by: CNBC Television
Sentiment: Positive
Zoetis CEO Kristin Peck joins 'Closing Bell Overtime' to talk its Avian Flu vaccine, the impact of tariffs, and more.
Read More
Zoetis: In-Line Q4 Earnings And Weak Guidance Present A Buying Opportunity
Published: February 13, 2025 by: Seeking Alpha
Sentiment: Positive
Zoetis' Q4 earnings met expectations, but the stock fell due to slowing growth and cautious 2025 guidance, presenting a buying opportunity around $163/share. Zoetis' unique advantages and pricing power in animal health, coupled with high R&D investment and a wide moat, make it a strong long-term play on emerging market growth. Despite regulatory risks and currency headwinds, Zoetis' dependable earnings and high operating margins justify a 12-month price target of $200/share.
Read More
Zoetis forecasts 2025 profit, revenue below estimates; shares fall
Published: February 13, 2025 by: Reuters
Sentiment: Negative
Animal healthcare company Zoetis forecast annual profit and revenue below Wall Street estimates on Thursday, partly due to a hit from a stronger dollar, sending its shares down 9% in premarket trading.
Read More
Zoetis Reports Fourth Quarter and Full Year 2024 Results
Published: February 13, 2025 by: Business Wire
Sentiment: Neutral
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE: ZTS) today reported its financial results for the fourth quarter and full year 2024 as well as provided full year guidance for 2025. The company reported revenue of $2.3 billion for the fourth quarter of 2024, an increase of 5% compared with the fourth quarter of 2023. On an operational1 basis, revenue for the fourth quarter of 2024 increased 6% compared with the fourth quarter of 2023. Net income for the fourth quarter of 2024 was $581 mill.
Read More
About Zoetis Inc. (ZTS)
- IPO Date 2013-02-01
- Website https://www.zoetis.com
- Industry Drug Manufacturers - Specialty & Generic
- CEO Kristin C. Peck
- Employees 13800